|
US5596001A
(en)
*
|
1993-10-25 |
1997-01-21 |
Pfizer Inc. |
4-aryl-3-(heteroarylureido)quinoline derivatves
|
|
US5576338A
(en)
*
|
1995-02-15 |
1996-11-19 |
Merck Frosst Canada, Inc. |
Bis (biaryl) compounds as inhibitors of leukotriene biosynthesis
|
|
US20010051719A1
(en)
*
|
1996-12-19 |
2001-12-13 |
Smithkline Beecham P.L.C. |
Novel compounds
|
|
US6376670B1
(en)
*
|
1997-06-19 |
2002-04-23 |
Sepracor Inc. |
Quinoline-indole antimicrobial agents, uses and compositions related thereto
|
|
AU757059B2
(en)
*
|
1997-06-19 |
2003-01-30 |
Sepracor, Inc. |
Quinoline-indole antimicrobial agents, uses and compositions related thereto
|
|
US6207679B1
(en)
*
|
1997-06-19 |
2001-03-27 |
Sepracor, Inc. |
Antimicrobial agents uses and compositions related thereto
|
|
IL133870A0
(en)
*
|
1997-07-11 |
2001-04-30 |
Smithkline Beecham Plc |
Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation
|
|
GB9801392D0
(en)
*
|
1998-01-22 |
1998-03-18 |
Smithkline Beecham Plc |
Novel compounds
|
|
GB9818916D0
(en)
*
|
1998-08-28 |
1998-10-21 |
Smithkline Beecham Plc |
Use
|
|
GB9820113D0
(en)
*
|
1998-09-15 |
1998-11-11 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
US6403808B1
(en)
*
|
1999-12-10 |
2002-06-11 |
Virginia Commonwealth University |
Selective 5-HT6 receptor ligands
|
|
US6310212B1
(en)
*
|
2000-03-28 |
2001-10-30 |
Neurogen Corporation |
4-substituted quinoline derivatives
|
|
GB0021450D0
(en)
*
|
2000-08-31 |
2000-10-18 |
Smithkline Beecham Plc |
Novel compounds
|
|
KR100823908B1
(ko)
*
|
2000-10-20 |
2008-04-21 |
바이오비트럼 에이비(피유비엘) |
2-, 3-, 4-, 또는 5-치환-ｎ1-(벤젠술포닐)인돌 및 이의치료 용도
|
|
DE10053813A1
(de)
*
|
2000-10-30 |
2002-05-08 |
Bayer Ag |
Neue Verwendung von Sulfonamiden
|
|
US6849644B2
(en)
*
|
2000-11-21 |
2005-02-01 |
Smithkline Beecham P.L.C. |
Isoquinoline derivatives useful in the treatment of CNS disorders
|
|
ES2271124T3
(es)
*
|
2000-11-24 |
2007-04-16 |
Smithkline Beecham Plc |
Compuestos indolil-sulfonilicos utiles en el tratamiento de trastornos del snc.
|
|
RU2294932C2
(ru)
*
|
2001-06-07 |
2007-03-10 |
Ф.Хоффманн-Ля Рош Аг |
Новые производные индола со сродством к рецептору 5-ht6
|
|
ITRM20010356A1
(it)
*
|
2001-06-21 |
2002-12-23 |
Sigma Tau Ind Farmaceuti |
"5-alogeno derivati della triptamina utili come ligandi del recettore5-ht6 e/o 5-ht7 della serotonina.
|
|
EP1456178A1
(en)
*
|
2001-12-21 |
2004-09-15 |
Smithkline Beecham Plc |
7-sulfonyl-3-benzazepine derivatives as modulators of the dopamine receptor and their use for the treatment of cns disorders
|
|
EP1472544A2
(en)
*
|
2002-02-01 |
2004-11-03 |
Bayer HealthCare AG |
Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor
|
|
GB0202679D0
(en)
*
|
2002-02-05 |
2002-03-20 |
Glaxo Group Ltd |
Novel compounds
|
|
US20050090485A1
(en)
*
|
2002-02-13 |
2005-04-28 |
Bromidge Steven M. |
7-Arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo'diazepine derivatives with 5ht6 receptor affinity for the reatment of cns disorders
|
|
AR039127A1
(es)
*
|
2002-03-27 |
2005-02-09 |
Glaxo Group Ltd |
Compuesto de quinolina, procedimiento para su preparacion, composicion farmaceutica que lo comprende y uso del mismo para la fabricacion de un medicamento
|
|
JP4754821B2
(ja)
*
|
2002-06-20 |
2011-08-24 |
プロキシマゲン・リミテッド |
肥満症、ｉｉ型糖尿病およびｃｎｓ障害の治療に有用な新規化合物
|
|
EP1569638B1
(en)
*
|
2002-12-03 |
2007-09-05 |
F. Hoffmann-La Roche Ag |
Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders
|
|
WO2004074286A1
(en)
*
|
2003-02-14 |
2004-09-02 |
Wyeth |
Heterocyclyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands
|
|
GB0305575D0
(en)
*
|
2003-03-11 |
2003-04-16 |
Glaxo Group Ltd |
Novel compounds
|
|
GB0321473D0
(en)
*
|
2003-09-12 |
2003-10-15 |
Glaxo Group Ltd |
Novel compounds
|
|
GB0322510D0
(en)
*
|
2003-09-25 |
2003-10-29 |
Glaxo Group Ltd |
Novel compounds
|
|
PT1667975E
(pt)
*
|
2003-09-26 |
2008-02-29 |
Glaxo Group Ltd |
Forma polimórfica de 3-fenilsulfonil-8-piperazin-1-il-quinolina
|
|
SE0302760D0
(sv)
*
|
2003-10-20 |
2003-10-20 |
Biovitrum Ab |
New compounds
|
|
WO2005066157A1
(en)
*
|
2004-01-02 |
2005-07-21 |
Suven Life Sciences |
3-(pyrolidin-3-l) indoles as 5-ht6 receptor modulators
|
|
GB0407025D0
(en)
*
|
2004-03-29 |
2004-04-28 |
Glaxo Group Ltd |
Novel compounds
|
|
GB0411421D0
(en)
*
|
2004-05-21 |
2004-06-23 |
Glaxo Group Ltd |
Novel compounds
|
|
DK1753764T3
(da)
*
|
2004-06-09 |
2009-02-16 |
Glaxo Group Ltd |
Pyrrolopyridin-derivater
|
|
GB0425548D0
(en)
*
|
2004-11-19 |
2004-12-22 |
Glaxo Group Ltd |
Radiolabelled ligands
|